Yunan Chen
Publications
- 2022
Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials
Reich, K., DeLozier, A. M., Nunes, F. P., Thyssen, J. P., Eichenfield, L. F., Wollenberg, A., Ross Terres, J. A., Watts, S. D., Chen, Y-F., Simpson, E. L. & Silverberg, J. I., 05.2022, In: J DERMATOL TREAT. 33, 3, p. 1521-1530 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review